These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11979370)
21. Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma. Bisegna C; Gravina GL; Pierconti F; Martini M; Larocca L; Rossi P; Grimaldi P; Dolci S; Di Stasi S; Jannini EA Andrology; 2020 Mar; 8(2):427-433. PubMed ID: 31433119 [TBL] [Abstract][Full Text] [Related]
22. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Zeng L; Rowland RG; Lele SM; Kyprianou N Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Tezel G; Chauhan BC; LeBlanc RP; Wax MB Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3025-33. PubMed ID: 12824248 [TBL] [Abstract][Full Text] [Related]
24. Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate. Yenice S; Davis AT; Goueli SA; Akdas A; Limas C; Ahmed K Prostate; 1994; 24(1):11-6. PubMed ID: 7507238 [TBL] [Abstract][Full Text] [Related]
25. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425 [TBL] [Abstract][Full Text] [Related]
26. IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis. Royuela M; De Miguel MP; Bethencourt FR; Fraile B; Arenas MI; Paniagua R Growth Factors; 2000; 18(2):135-46. PubMed ID: 11019784 [TBL] [Abstract][Full Text] [Related]
27. Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Allard P; Zoubeidi A; Nguyen LT; Tessier S; Tanguay S; Chevrette M; Aprikian A; Chevalier S Mol Cell Endocrinol; 2000 Jan; 159(1-2):63-77. PubMed ID: 10687853 [TBL] [Abstract][Full Text] [Related]
28. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Uzgare AR; Kaplan PJ; Greenberg NM Prostate; 2003 May; 55(2):128-39. PubMed ID: 12661038 [TBL] [Abstract][Full Text] [Related]
29. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693 [TBL] [Abstract][Full Text] [Related]
30. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related]
32. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972 [TBL] [Abstract][Full Text] [Related]
33. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991 [TBL] [Abstract][Full Text] [Related]
34. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. Joo SS; Yoo YM J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739 [TBL] [Abstract][Full Text] [Related]
35. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Tang DG; Li L; Chopra DP; Porter AT Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682 [TBL] [Abstract][Full Text] [Related]
36. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Leav I; McNeal JE; Ho SM; Jiang Z Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556 [TBL] [Abstract][Full Text] [Related]
37. Expression of mitogen-activated protein kinase family in rat renal development. Omori S; Hida M; Ishikura K; Kuramochi S; Awazu M Kidney Int; 2000 Jul; 58(1):27-37. PubMed ID: 10886546 [TBL] [Abstract][Full Text] [Related]
38. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
39. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Li W; Wu CL; Febbo PG; Olumi AF Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894 [TBL] [Abstract][Full Text] [Related]
40. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W; Liao QY; Hantash FM; Sanders BG; Kline K Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]